Clinical Trials
2 trialsNCT05626400 2022-11-25
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Recruiting
NCT04785833 2021-03-08
CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase NA Unknown